Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 8, 2018International Journal of Molecular SciencesOpen Access

mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

HWHannah WaltersLCLynne S. Cox

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Walters et al. (2018) studied this question.

synapsesocial.com/papers/6a701ee878a11c550e09ef63https://doi.org/10.3390/ijms19082325
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization2002 · 4,049 citations
  2. 2Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system2015 · 187 citations
  3. 3Reversal of phenotypes of cellular senescence by pan-mTOR inhibition2016 · 115 citations
  4. 4Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: A prospective cohort study2017 · 155 citations
  5. 5Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion2012 · 128 citations